Skip to content
Menu

Acrivon Therapeutics, Inc. ACRV

Full chart Compare
Set alert

Price alert · ACRV

All alert types
1.15 USD -0.25 (-17.86%)

Regular-session close

1.24 +0.09 +7.83%

After hours · Nov 20, 4:19 PM ET

0.9709 Day range 1.40
1.15 52-week range 3.01
YTD
-52.28%
1 year
-49.12%

Ownership

  • Institutions 76.0%
  • Insiders 22.4%
  • Public and other holders 1.64%
Held by insiders 22.39%
Held by institutions 75.98%
Float held by institutions 97.89%
Institutions 86

Top institutional holders

Top institutional holders
Holder% heldSharesValueReported
RA Capital Management, L.P.26.79%8,340,50851.96MSep 29, 2024
Perceptive Advisors Llc17.22%5,360,85833.40MSep 29, 2024
Citadel Advisors Llc6.88%2,140,62813.34MSep 29, 2024
Sands Capital Ventures, LLC6.82%2,122,60513.22MSep 29, 2024
Wellington Management Group, LLP2.85%888,1305.53MSep 29, 2024
Marshall Wace LLP2.60%809,8595.05MSep 29, 2024

Top mutual fund holders

Top mutual fund holders
Holder% heldSharesValueReported
Vanguard Total Stock Market Index Fund1.24%387,4072.41MSep 29, 2024
iShares Russell 2000 ETF0.91%281,9511.76MOct 30, 2024
Vanguard Extended Market Index Fund0.53%164,2141.02MSep 29, 2024
Fidelity Small Cap Index Fund0.38%119,298743.23KAug 30, 2024
iShares Russell 2000 Value ETF0.37%115,408718.99KOct 30, 2024
Schwab Strategic Tr-Schwab U.S. Small Cap ETF0.29%89,261556.10KAug 30, 2024

Included in Plus and up

Sign in to see Institutional ownership

How much funds own from their 13F filings, quarter by quarter, and the largest holders.

Free with an account

Sign in to see Insider activity

Two years of insider buying and selling by month, marked on the price.

Included in Plus and up

Sign in to see Congress trading

Every stock trade disclosed by members of the US Senate and House.

Free with an account

Sign in to see CEO compensation

What the chief executive was paid each year, by salary, bonus and stock, beside the company's earnings.

Free with an account

Sign in to see Board of directors

Who sits on the board, who chairs it, and how long each director has served.

ACRV insiders
InsiderRelationLatest transactionDateShares held
BLUME-JENSEN PETERChief Executive OfficerStock Award(Grant)Aug 20, 20233,218,400
CHIONE, LTD.Beneficial Owner of more than 10% of a Class of SecuritySaleJun 25, 20230
DEVROE ERICChief Operating OfficerConversion of Exercise of derivative securityMay 16, 202469,097
HOLM-JORGENSEN RASMUSChief Financial OfficerConversion of Exercise of derivative securityJun 15, 202329,530
MILLER MARYOfficerStock Award(Grant)Sep 25, 202344,287
PERCEPTIVE ADVISORS, L.L.C.Beneficial Owner of more than 10% of a Class of SecurityPurchaseApr 10, 20240